We have isolated, by immunological screening of a lambda gt11 expression library, a cDNA clone that represents the complete coding sequence for bovine alpha 1----3-galactosyltransferase. The coding sequence predicts a membrane-bound protein with three distinct structural features: a large, potentially glycosylated COOH-terminal domain (346 amino acids), a single transmembrane domain (16 amino acids), and a short NH2-terminal domain (6 amino acids). Thus, the domain structure for this transferase is similar to that deduced for beta 1----4-galactosyltransferase (Shaper, N. L., Hollis, G. F., Douglas, J. G., Kirsch, I. R., and Shaper, J. H. (1988) J. Biol. Chem. 263, 10420-10428) and alpha 2----6-sialyltransferase (Weinstein, J., Lee, E. V., McEntee, K., Lai, P.-H., and Paulson, J. C. (1987) J. Biol. Chem. 262, 17735-17743). S1 analysis demonstrates that two sets of mRNAs, which are heterogeneous at their 5' ends, are transcribed. Because both sets initiate upstream of the translational start site, only one protein is encoded by this gene. alpha 1----3-Galactosyltransferase is widely expressed in different mammalian species, with the notable exception of man and Old World monkeys (Galili, U., Shohet, S. B., Kobrin, E., Stults, C.L.M., and Macher, B. A. (1988) J. Biol. Chem. 263, 17755-17762). By Northern blot analysis we were indeed unable to detect transcripts for this enzyme in various human and Old World monkey cell lines; transcripts were readily detected in other mammalian species. However, by Southern blot analysis, homologous sequences for alpha 1----3-galactosyltransferase were identified in human genomic DNA. This suggests that the gene, although present in the human genome, is normally not expressed. These observations have potential medical implications. Because many humans have high levels of circulating antibodies directed against the enzymatic product of alpha 1----3-galactosyltransferase (Gal alpha 1----3Gal beta 1----4GlcN Ac) (Galili, U., Clark, M. R., Shohet, S. B., Buehler, J., and Macher, B. A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 1369-1373), it has been suggested that activation of this normally silent gene may play a role in autoimmune disease in man (Etienne-Decerf, J., Malaise, M., Mahieu, P., and Winand, R. (1987) Acta Endocrinol. 115, 67-74).
Citing Articles
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy.
Galili U
Pharmaceutics. 2024; 16(10).
PMID: 39458595
PMC: 11510312.
DOI: 10.3390/pharmaceutics16101263.
Physiological basis for xenotransplantation from genetically modified pigs to humans.
Peterson L, Yacoub M, Ayares D, Yamada K, Eisenson D, Griffith B
Physiol Rev. 2024; 104(3):1409-1459.
PMID: 38517040
PMC: 11390123.
DOI: 10.1152/physrev.00041.2023.
Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U
Med Res Arch. 2021; 9(7).
PMID: 34853815
PMC: 8631339.
DOI: 10.18103/mra.v9i7.2481.
Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
Galili U
Front Mol Biosci. 2021; 8:746883.
PMID: 34805272
PMC: 8601398.
DOI: 10.3389/fmolb.2021.746883.
Biomanufacturing of Axon-Based Tissue Engineered Nerve Grafts Using Porcine GalSafe Neurons.
Katiyar K, Burrell J, Laimo F, Browne K, Bianchi J, Walters A
Tissue Eng Part A. 2021; 27(19-20):1305-1320.
PMID: 33514288
PMC: 8610031.
DOI: 10.1089/ten.TEA.2020.0303.
Possible Link Between the ABO Blood Group of Bioprosthesis Recipients and Specific Types of Structural Degeneration.
Schussler O, Lila N, Grau J, Ruel M, Lecarpentier Y, Carpentier A
J Am Heart Assoc. 2020; 9(15):e015909.
PMID: 32698708
PMC: 7792238.
DOI: 10.1161/JAHA.119.015909.
Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections.
Galili U
Antibodies (Basel). 2020; 9(2).
PMID: 32580274
PMC: 7344964.
DOI: 10.3390/antib9020025.
Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses.
Schussler O, Lila N, Perneger T, Mootoosamy P, Grau J, Francois A
EBioMedicine. 2019; 42:54-63.
PMID: 30878598
PMC: 6491382.
DOI: 10.1016/j.ebiom.2019.02.047.
Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G, Qi P, Yang H, Wang Y
Int J Mol Med. 2015; 37(1):11-20.
PMID: 26531137
PMC: 4687435.
DOI: 10.3892/ijmm.2015.2397.
Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.
Galili U
J Mol Evol. 2014; 80(1):1-9.
PMID: 25315716
DOI: 10.1007/s00239-014-9652-x.
An integrative evolution theory of histo-blood group ABO and related genes.
Yamamoto F, Cid E, Yamamoto M, Saitou N, Bertranpetit J, Blancher A
Sci Rep. 2014; 4:6601.
PMID: 25307962
PMC: 5377540.
DOI: 10.1038/srep06601.
Glycosylation of conotoxins.
Gerwig G, Hocking H, Stocklin R, Kamerling J, Boelens R
Mar Drugs. 2013; 11(3):623-42.
PMID: 23455513
PMC: 3705362.
DOI: 10.3390/md11030623.
Molecular genetic basis of the human Forssman glycolipid antigen negativity.
Yamamoto M, Cid E, Yamamoto F
Sci Rep. 2012; 2:975.
PMID: 23240079
PMC: 3521167.
DOI: 10.1038/srep00975.
Anti-gal antibodies in α1,3-galactosyltransferase gene-knockout pigs.
Fang J, Walters A, Hara H, Long C, Yeh P, Ayares D
Xenotransplantation. 2012; 19(5):305-10.
PMID: 22970769
PMC: 3444635.
DOI: 10.1111/j.1399-3089.2012.00710.x.
Allelic variation of the porcine alpha-1,3-galactosyltransferase 1 (GGTA1) gene.
Day A, Rocha D
J Appl Genet. 2008; 49(1):75-9.
PMID: 18263972
DOI: 10.1007/BF03195251.
The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.
Macher B, Galili U
Biochim Biophys Acta. 2007; 1780(2):75-88.
PMID: 18047841
PMC: 2271034.
DOI: 10.1016/j.bbagen.2007.11.003.
Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
Abdel-Motal U, Guay H, Wigglesworth K, Welsh R, Galili U
J Virol. 2007; 81(17):9131-41.
PMID: 17609270
PMC: 1951452.
DOI: 10.1128/JVI.00647-07.
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.
Koike C, Uddin M, Wildman D, Gray E, Trucco M, Starzl T
Proc Natl Acad Sci U S A. 2006; 104(2):559-64.
PMID: 17194757
PMC: 1766424.
DOI: 10.1073/pnas.0610012104.
Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.
Ogawa H, Galili U
Glycoconj J. 2006; 23(9):663-74.
PMID: 17115279
DOI: 10.1007/s10719-006-9005-0.
Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother. 2004; 53(11):935-45.
PMID: 15205919
PMC: 11032768.
DOI: 10.1007/s00262-004-0524-x.